SCOPUS 정보 검색 플랫폼

British Journal of Cancer

Volumn 99, Issue 3, 2008, Pages 385-386

Promises and caveats of in silico biomarker discovery

(2) Pusztai, L a Leyland Jones, B b

a UNIVERSITY OF TEXAS (United States)

b EMORY UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER MODEL; DIAGNOSTIC ACCURACY; EDITORIAL; GENE EXPRESSION; HORMONAL THERAPY; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 48349087525 PISSN: 00070920 EISSN: 15321827 Source Type: Journal
DOI: 10.1038/sj.bjc.6604495 Document Type: Editorial

Times cited : (4)

References (5)

1
- 34247508923
- Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer
- Andre F, Hatzis C, Anderson K, Sotiriou C, Mazouni C, Mejia J, Wang B, Hortobagyi GN, Symmans WF, Pusztai L (2007) Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer. Clin Cancer Res 13: 2061-2067
- (2007) Clin Cancer Res , vol.13 , pp. 2061-2067
- Andre, F.¹ Hatzis, C.² Anderson, K.³ Sotiriou, C.⁴ Mazouni, C.⁵ Mejia, J.⁶ Wang, B.⁷ Hortobagyi, G.N.⁸ Symmans, W.F.⁹ Pusztai, L.¹⁰

2
- 48349114664
- PRAME expression and clinical outcome of breast cancer
- in press
- Epping MT, Hart AAM, Glas AM, Krijgsman O, Bernards R (2008) PRAME expression and clinical outcome of breast cancer. Br J Cancer (in press)
- (2008) Br J Cancer
- Epping, M.T.¹ Hart, A.A.M.² Glas, A.M.³ Krijgsman, O.⁴ Bernards, R.⁵

3
- 34249942379
- Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
- Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA (2007) Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system. J Clin Oncol 25: 2127-2132
- (2007) J Clin Oncol , vol.25 , pp. 2127-2132
- Hudis, C.A.¹ Barlow, W.E.² Costantino, J.P.³ Gray, R.J.⁴ Pritchard, K.I.⁵ Chapman, J.A.⁶ Sparano, J.A.⁷ Hunsberger, S.⁸ Enos, R.A.⁹ Gelber, R.D.¹⁰ Zujewski, J.A.¹¹

4
- 33644830699
- Reporting recommendations for tumor marker prognostic studies
- McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23: 9067-9072
- (2005) J Clin Oncol , vol.23 , pp. 9067-9072
- McShane, L.M.¹ Altman, D.G.² Sauerbrei, W.³ Taube, S.E.⁴ Gion, M.⁵ Clark, G.M.⁶

5
- 33644688970
- Roadmap for developing and validating therapeutically relevant genomic classifiers
- Simon R (2005) Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 23: 7332-7341
- (2005) J Clin Oncol , vol.23 , pp. 7332-7341
- Simon, R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.